ask="N/A"
ask_size="N/A"
average_daily_volume="1071020"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+1.68"
change_from_200_day_moving_average="1.76"
change_from_50_day_moving_average="3.75"
change_from_52_week_high="-7.89"
change_From_52_week_low="14.91"
change_in_percent="+3.69%"
close="47.26"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.83"
ex_dividend_date="N/A"
float_shares="85906000"
high="47.43"
high_52_weeks="55.15"
last_trade_date="3/15/2017"
last_trade_price="47.26"
last_trade_size="48184"
last_trade_time="4:00pm"
low="45.73"
low_52_weeks="32.35"
market_capitalization="4.12B"
moving_average_200_day="45.50"
moving_average_50_day="43.51"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="45.73"
pe_ratio="N/A"
peg_ratio="0.53"
percent_change_from_200_day_moving_average="+3.87%"
percent_change_from_50_day_moving_average="+8.63%"
percent_change_from_52_week_high="-14.31%"
percent_change_from_52_week_low="+46.09%"
previous_close="45.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.58"
price_per_sales="264.71"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="4.06"
stock_exchange="NMS"
symbol="NBIX"
volume="747815"
weeks_range_52="32.35 - 55.15"
